期刊
THERAPEUTIC ADVANCES IN UROLOGY
卷 9, 期 1, 页码 -出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1756287216677903
关键词
metastatic urothelial carcinoma; second line; mTCCU; urothelial cancer; vinflunine
Vinflunine (VFL) has been approved in Europe for second-line treatment of metastatic and advanced urothelial cancer after failure of platin-containing therapy. Since approval, the drug has been investigated in few clinical trials. Most of the currently available reports describe experiences with VFL in a daily clinical setting. This review gives a short overview on clinical experiences and clinical trials involving VFL since the approval of this drug in 2009.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据